Method of Treating Organophosphorous Poisoning

A method for preventing organophosphorus poisoning in an animal that is at risk of repeated exposure to sublethal doses of an organophosphorus compound, comprising administering a therapeutically effective amount of galantamine or a salt thereof, or a biologically active analog, derivative, fragment or variant thereof up to three times per day for a duration of the risk.

A pharmaceutical composition comprising galantamine or a salt thereof, or a biologically active analog, derivative, fragment or variant thereof and atropine or a salt thereof, or a biologically active analog, derivative, fragment or variant thereof.

A method of treating or preventing the loss of cognitive function or neuronal degeneration in an animal after organophosphorus poisoning, comprising administering a therapeutically effective amount of galantamine or a salt thereof, or a biologically active analog, derivative, fragment or variant thereof.

A method of treating or preventing intermediate syndrome in an animal that is at risk of developing it, comprising administering a therapeutically effective amount of galantamine or a salt thereof, or a biologically active analog, derivative, fragment or variant thereof.